These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25854960)

  • 1. A total internal reflection ellipsometry and atomic force microscopy study of interactions between Proteus mirabilis lipopolysaccharides and antibodies.
    Gleńska-Olender J; Sęk S; Dworecki K; Kaca W
    Eur Biophys J; 2015 Jul; 44(5):301-7. PubMed ID: 25854960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Proteus mirabilis Antigen Immunological Complexes by Atomic Force Microscopy.
    Kaca W; Gleńska-Olender J; Konieczna I; Gawęda J; Sęk S
    Methods Mol Biol; 2019; 2021():273-283. PubMed ID: 31309512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human antibodies binding with smooth and rough LPSs from Proteus mirabilis O3 strains S1959, R110, R45.
    Gleńska-Olender J; Durlik K; Konieczna I; Kowalska P; Gawęda J; Kaca W
    Antonie Van Leeuwenhoek; 2017 Nov; 110(11):1435-1443. PubMed ID: 28889208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies Isolated from Rheumatoid Arthritis Patients against Lysine-Containing
    Durlik-Popińska K; Żarnowiec P; Lechowicz Ł; Gawęda J; Kaca W
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECA-immunogenicity of Proteus mirabilis strains.
    Duda KA; Duda KT; Beczała A; Kasperkiewicz K; Radziejewska-Lebrecht J; Skurnik M
    Arch Immunol Ther Exp (Warsz); 2009; 57(2):147-51. PubMed ID: 19333729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cross-reactivity of Shewanella fidelis lipopolysaccharide with anti-Proteus antibodies.
    Kwinkowski M; Grabowski S; Konieczna I; Nazarenko EL; Kaca W
    Pol J Microbiol; 2009; 58(3):275-8. PubMed ID: 19899622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
    Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serological reactions of Rickettsiae-infected patients and rabbit anti-Proteus OX antibodies with Proteus OX2, OX19 and OXK lipopolysaccharides.
    Amano K; Cedzyński M; Swierzko AS; Kyohno K; Kaca W
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):235-40. PubMed ID: 9017163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis.
    Arabski M; Fudala R; Koza A; Wasik S; Futoma-Koloch B; Bugla-Ploskonska G; Kaca W
    Clin Biochem; 2012 Nov; 45(16-17):1374-82. PubMed ID: 22749779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
    Kaca W; Literacka E; Sjöholm AG; Weintraub A
    J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
    Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and serological studies of the O-antigen of the bacterium Proteus mirabilis OXK (serogroup O3) used in the Weil-Felix test.
    Swierzko AS; Cedzynski M; Knirel YuA ; Senchenkova SN; Kocharova NA; Shashkov AS; Amano KI; Kyohno K; Kaca W
    Biochemistry (Mosc); 1997 Jan; 62(1):21-7. PubMed ID: 9113725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-scrub typhus rickettsia and rabbit anti-Proteus antibodies recognize similar epitope in the O-polysaccharide part of Proteus mirabilis OXK lipopolysaccharide.
    Kaca W; Amano K; Chernyak AY; Knirel YA
    Microbios; 2000; 103(406):151-61. PubMed ID: 11131808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of synthetic antigens in studies of antigenic specificity of Proteus mirabilis 027 lipopolysaccharide].
    Krajewska-Pietrasik D; Cherniak AY; Rózalski A
    Med Dosw Mikrobiol; 1995; 47(3-4):169-76. PubMed ID: 8833928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of epitope specificity of polyclonal antibodies against Proteus mirabilis R mutants].
    Bartodziejska B; Radziejewska-Lebrecht J; Lipińska M; Ziółkowski A; Rózalski A
    Med Dosw Mikrobiol; 1993; 45(1):99-102. PubMed ID: 7694017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
    Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J
    Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-producing cell responses to an isolated outer membrane protein and to complexes of this antigen with lipopolysaccharide or with vesicles of phospholipids from Proteus mirabilis.
    Karch H; Nixdorff K
    Infect Immun; 1981 Mar; 31(3):862-7. PubMed ID: 6164651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Proteus mirabilis O3 (S1959), O9 and O18 strains in normal human serum (NHS) correlates with the diversity of their outer membrane proteins (OMPs).
    Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W; Kaca W
    Pol J Microbiol; 2006; 55(2):153-6. PubMed ID: 17419294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 response in cells from the human urinary tract induced by lipopolysaccharides of Proteus mirabilis O3 and O18.
    Chromek M; Stankowska D; Dadfar E; Kaca W; Rabbani H; Brauner A
    J Urol; 2005 Apr; 173(4):1381-4. PubMed ID: 15758809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of the lipopolysaccharide from Proteus mirabilis O27.
    Krajewska D; Gromska W
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):581-7. PubMed ID: 6751282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.